Stock listing
Immatics N.v.
Selected listing: A2P72S · LS · EUR · DE
Immatics N.v. (Lang & Schwarz: A2P72S), Health Technology. Latest release Aug 25, 2026: Immatics Announces $150 Million Underwritten Offering.
- Ticker
- Lang & Schwarz: A2P72S
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Lang & Schwarz
- Currency
- EUR
Latest news from Immatics N.v.
Immatics Announces $150 Million Underwritten Offering
August 25, 2026
Immatics N : Announces Second Quarter 2026 Financial Results and Business Update
August 18, 2026
Immatics Announces Second Quarter 2026 Financial Results and Business Update
August 18, 2026
Immunomic Therapeutics Announces First Patient Dosed in Phase 1 Trial of Cancer Vaccine Candidate ITI-5000
July 20, 2026
Immatics Announces Upcoming Presentations Across Its PRAME Franchise at ESMO Congress 2026
July 17, 2026
Research Immatics N.v.
Alternate listings
IMTX:NASDAQ
US · USD
Alternate listing for Immatics N.v.; the primary context on this page is A2P72S:LS.
4A3:TRADEGATE
DE · EUR
Alternate listing for Immatics N.v.; the primary context on this page is A2P72S:LS.
4A3:FWB
DE · EUR
Alternate listing for Immatics N.v.; the primary context on this page is A2P72S:LS.
4A3:GETTEX
DE · EUR
Alternate listing for Immatics N.v.; the primary context on this page is A2P72S:LS.
A2P72S:LSX
DE · EUR
Alternate listing for Immatics N.v.; the primary context on this page is A2P72S:LS.
4A3:SWB
DE · EUR
Alternate listing for Immatics N.v.; the primary context on this page is A2P72S:LS.
IMTX:BOATS
US · USD
Alternate listing for Immatics N.v.; the primary context on this page is A2P72S:LS.
4A3:DUS
DE · EUR
Alternate listing for Immatics N.v.; the primary context on this page is A2P72S:LS.
4A3:HAM
DE · EUR
Alternate listing for Immatics N.v.; the primary context on this page is A2P72S:LS.
4A3:MUN
DE · EUR
Alternate listing for Immatics N.v.; the primary context on this page is A2P72S:LS.